The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Gut Instinct: Ankylosing Spondylitis & the Microbiome

Gut Instinct: Ankylosing Spondylitis & the Microbiome

October 3, 2019 • By Jason Liebowitz, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Anatomy Insider / shutterstock.comCHICAGO—At the 2019 ACR State-of-the-Art Clinical Symposium, an annual gathering featuring talks by key opinion leaders on the most salient topics for practicing rheumatologists and healthcare providers, Jose U. Scher, MD, director of the Microbiome Center for Rheumatology and Autoimmunity at NYU Langone Medical Center, New York City, was the featured speaker. In his remarks, Dr. Scher discussed fascinating findings from more than a decade’s worth of research examining the relationship between bacteria throughout the body, such as in the lungs and gastrointestinal tract, and inflammatory diseases, such as rheumatoid arthritis.

You Might Also Like
  • Probing the Role of Genes & Microbiome in Ankylosing Spondylitis & RA
  • Researchers Explore HLA-B27’s Role in the Development of Spondylitis
  • Gut-on-a-Chip Provides Insight into Microbiome & Intestinal Inflammation
Explore This Issue
March 2020
Also By This Author
  • Exciting Advances in Giant Cell Arteritis Diagnosis & Treatment

Several interesting questions were raised in the talk, among them, “Can certain bacteria trigger an autoimmune response in patients who develop rheumatologic disease?” and “Can one modify the microbiome to prevent or treat autoimmunity?” The potential hypotheses that emerged were tantalizing, and selection of this topic as the theme of the keynote address speaks to the timely importance of understanding the role the microbiome plays in autoimmunity.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Symbiotic Interplay
One area that has attracted particular attention, Dr. Scher noted, is the relationship between spondyloarthritis and the microbiome. Research has shown the microbial cells of the human gut outnumber host cells by a ratio of 10 to 1 and contain 100-fold more genes than the human genome.1 Although clearly a symbiotic interplay exists between this plethora of varied bacteria and their host, with the former benefiting from host nutrients and the latter gaining metabolic and physiologic capabilities provided by these commensal bacteria, the interaction between gut flora and the immune system may yield collateral damage and explain some of the genetic associations seen in spondyloarthritis.

For example, the association between the human leukocyte antigen B27 (HLA-B27) allele and spondyloarthritis has been well established since the 1970s, but only in the 1990s was it shown that HLA-B27 transgenic rats that develop spondyloarthritis are free of colitis and arthritis when the animals are raised in a germ-free environment, and that these gut and joint inflammatory findings re-emerge when normal flora is re-introduced.2,3 Researchers have also shown that the cecal microbiota of HLA-B27 transgenic rats demonstrate differences in bacterial species compared to those of wild-type rats, and 16S microbial sequencing of the microbiomes in terminal ileal biopsies from ankylosing spondylitis patients vs. healthy controls confirmed that similar differences are seen in humans as well.4,5

José U. Scher, MD, Assistant Professor, Department of Medicine

José U. Scher, MD

Dr. Scher noted that James Rosenbaum, MD, professor of ophthalmology at Oregon Health and Science University, and Michael P. Davey, MD, PhD, professor of medicine, Division of Arthritis and Rheumatic Diseases of the School of Medicine at Oregon Health and Sciences University, have put forth a hypothesis: HLA-B27 influences the composition of the body’s endogenous flora and this “B27-shaped flora” causes ankylosing spondylitis.6 Although the pathogenesis of such a sequence remains unclear, CD4+ T cells may play a large role in activation of the interleukin 23 (IL-23)/IL-17 axis in both joint and gastrointestinal inflammation.7

Pages: 1 2 3 4 | Single Page

Filed Under: Conditions, Spondyloarthritis Tagged With: Ankylosing Spondylitis, gut microbiome, MicrobiomeIssue: March 2020

You Might Also Like:
  • Probing the Role of Genes & Microbiome in Ankylosing Spondylitis & RA
  • Researchers Explore HLA-B27’s Role in the Development of Spondylitis
  • Gut-on-a-Chip Provides Insight into Microbiome & Intestinal Inflammation
  • Letters: UCLA Study on HLA-B27 Link with Ankylosing Spondylitis at Forefront

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)